Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suman Kumar

Showing results (1-10 of 553) with videos related to

Pageof 56
Sort By:
JNMA; Journal of the Nepal Medical Association|May 19, 2023
Lumbosacral Transitional Vertebra among Patients Visiting the Department of Orthopaedics in a Tertiary Care Centre: A Descriptive Cross-sectional StudySuman Kumar Basel
The Analyst|February 19, 2024
Frequency-tuned selectivity enhancement of Mg@ZnO-TiO<sub>2</sub> nanoflake-based heterojunction sensor devicesSuman Kumar, Basanta Bhowmik
International Journal of Pediatric Otorhinolaryngology|November 13, 2010
Status of newborn hearing screening program in IndiaSuman Kumar, Bijoyaa Mohapatra
Current Stem Cell Research & Therapy|February 10, 2021
Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New ParadigmSuman Kumar Ray, Sukhes Mukherjee
Current Pharmaceutical Biotechnology|December 14, 2020
Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical BiotechnologySuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|January 18, 2022
Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But PlausibileSukhes Mukherjee, Suman Kumar Ray
Avicenna Journal of Medicine|December 9, 2021
COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending?Suman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|December 7, 2021
Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular MedicineSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|September 1, 2022
A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far?Suman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|February 9, 2022
Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health InterferenceSukhes Mukherjee, Suman Kumar Ray
Pageof 56

Showing results (1-10 of 553) with videos related to

Sort By:
Pageof 56
JNMA; Journal of the Nepal Medical Association|May 19, 2023
Lumbosacral Transitional Vertebra among Patients Visiting the Department of Orthopaedics in a Tertiary Care Centre: A Descriptive Cross-sectional StudySuman Kumar Basel
The Analyst|February 19, 2024
Frequency-tuned selectivity enhancement of Mg@ZnO-TiO<sub>2</sub> nanoflake-based heterojunction sensor devicesSuman Kumar, Basanta Bhowmik
International Journal of Pediatric Otorhinolaryngology|November 13, 2010
Status of newborn hearing screening program in IndiaSuman Kumar, Bijoyaa Mohapatra
Current Stem Cell Research & Therapy|February 10, 2021
Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New ParadigmSuman Kumar Ray, Sukhes Mukherjee
Current Pharmaceutical Biotechnology|December 14, 2020
Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical BiotechnologySuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|January 18, 2022
Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But PlausibileSukhes Mukherjee, Suman Kumar Ray
Avicenna Journal of Medicine|December 9, 2021
COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending?Suman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|December 7, 2021
Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular MedicineSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|September 1, 2022
A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far?Suman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|February 9, 2022
Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health InterferenceSukhes Mukherjee, Suman Kumar Ray
Pageof 56